Kulpreet barn retweetledi
From #pressor support to #impella support in #cardiogenicshock—how stable #pMCS enables #prehabilitation in the #ICU Gym and changes the trajectory. 💪
English
Kulpreet barn
271 posts
Kulpreet barn
@KulpreetBarn
advanced heart failure Cardilogist . director of advance heart failure/ mechanical circulatory program. advance heart failure program developer .
New Jersey, USA Katılım Mart 2020
503 Takip Edilen417 Takipçiler
@AndrewJSauer @drjohnm AHF cards actually spend a significant amount of time interacting with community. Most AHF programs have outreach clinics , CS transfer protocols and inpatient availability at there community based hospitals in there systems. we don’t sit in ivory towers waiting for pts :-)
English
Huh? So is the message that dedicated advanced heart failure and transplant cardiologists somehow don’t work to care for patients in the “community” ?
Especially heart failure?
Explain @drjohnm please.
John Mandrola, MD@drjohnm
Same for cardiology, especially heart failure 👇🏻
English
Kulpreet barn retweetledi
⚖️ Want to review the economic value of HF therapies?
Find that here:
📖 Read the report ➡️ onlinejcf.com/article/S1071-…
📺 Watch the highlights ➡️ youtu.be/0fq_wF4IxoU
YouTube
English
Kulpreet barn retweetledi
Here are all AHFTC fellowship programs that offered spots in last 5 years, and # of fellows they matched. 13 programs trained 50% of fellows. #HFSA2025 Skewed uneven distribution. Mega centers train most of the field. Insufficient exposure to community and rural needs. Worrisome.
English
Kulpreet barn retweetledi
🚧 The total direct costs for individuals with HF are estimated to be $227 billion in the US
HF-related costs are projected to grow significantly:
🚨 total direct medical costs for individuals with HF could rise to $858 billion by 2050
🎯 prioritize HF prevention and Rx
Gregg Fonarow MD@gcfmd
Just released in @JCardFail - the @HFSA HF Stats 2025 report! 📖 Read the report ➡️ onlinejcf.com/article/S1071-… 📺 Watch the highlights ➡️ youtu.be/0fq_wF4IxoU 🎯 Make these data count 👏 Special thanks to the entire writing group #HFStats2025 #heartfailurestats
English
Kulpreet barn retweetledi
ECMO is increasingly used a bridge to transplant. In this study of the UNOS database, use of #ECMO as a bridge to multiorgan #transplant was associated with increased 30 day mortality and decreased long-term survival @ElbertHeng @JW_MacArthur @StanfordCTSurg
🔗: jhltonline.org/article/S1053-…
English
Kulpreet barn retweetledi
3 out of 7 newly diagnosed ATTR-CM patients that I saw in 1 day didnt have ATTR-CM (2 on therapy). Just really tough to interpret PYP scans with blood pooling, and due to cavity size and shape they simply appeared as myocardial uptake to those reading them.
That is why we are running REVEAL (Evuzamitide in suspected cardiac amyloidosis). Cant afford making such mistakes.
clinicaltrials.gov/study/NCT06788…
#CardioTwitter #CVNuc
English
Kulpreet barn retweetledi
🧵Substrate-based vs. clinical VT ablation?!
In ischemic VT, should we pursue substrate mapping (sinus) vs. entrainment mapping (in VT) as ablation strategy?
VT recurrence at 12 months:
👉Substrate-based ablation 15%
👉 Clinical ablation 48%
VISTA Trial ⬇️
jacc.org/doi/full/10.10…
#Epeeps
English
Kulpreet barn retweetledi
@maybeadoc1983 @drbennisahmed @mvaduganathan @JavedButler1 SCD ⬇️ in HFrEF RCTs where GDMT mandated by trial protocol
In clinical practice, SCD, progressive HF☠️, and all-cause ☠️ all ⬆️ since massive gaps in use and dosing in GDMT + rising HF incidence (w/o age adjustment)
Want to save 100,000 lives a year?
Apply GDMT by protocol
English
I am happy to announce today that I have started as Medical Director of Heart Failure of Robert Wood Johnson Barnabas Health (RWJBH) system. I would like to thank the leadership at RWJBH for giving me the honor and privilege to serve this region. My home state of New Jersey!
English
@ReyentovichHFMD @nyulangone @yaleHFdoc @JasonKatzMD @KadoshBernard @ShalineRaoMD Hopefully we start seeing it as LVAD plus/ or transplant rather than “ vs” !
English
The great debate LVAD vs tx @nyulangone Advanced HF Conference making the case for LVADs-“no one wants an LVAD until they need an LVAD” before @yaleHFdoc gives his counter. @JasonKatzMD @KadoshBernard @ShalineRaoMD
English
Excellent collaboration with the heart and kidney team @nyulangone to combine an LVAD implant with xeno kidney giving our patient a chance at life. Thank you to our patient and her family as well as our close collaborator
@KulpreetBarn apnews.com/article/pig-or…
English
@ReyentovichHFMD @nyulangone This patient is very lucky to have the best team around her . No surprise she is doing so well. Congrats to the entire team @nyulangone
English
Kulpreet barn retweetledi
We are pleased to inform that our DOT-HM3 Trial results in partnership between IKEM and The Brigham Harvard just got online! Our results suggest a safety signal of Apixaban use with the HM3 up to a 6-months time point in stable LVAD patients. ahajournals.org/doi/abs/10.116…
English
@ShashankSinhaMD @NavinKapur4 @manreetkanwar @JHMontfort10 @ReshadGaranMD @BurkhoffMd @JasonKatzMD Most advance centers are already doing this and add PA Catheter to guide therapy. What this trial really shows is that temporary MCS should be used early in the community and get these pts to local advance centers asap like left main or aortic dissection.
English
🔥🔥🔥DanGer Shock shocks the 🌎 Congrats to Dr Jacob Møller & colleagues on executing this trial! So much to learn & unpack. #ShockFam How will these results change your clinical practice? 🤔 @NavinKapur4 @manreetkanwar @JHMontfort10 @ReshadGaranMD @BurkhoffMd @JasonKatzMD
NEJM@NEJM
Presented today at #ACC24: In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: nej.md/3xyXU3t
English
Kulpreet barn retweetledi
Amazing talk by Dr. @KulpreetBarn on evolving landscape of HFpEF @ACPNJ1 24
Main takeaways:
🌟SGLT2i: Only GDMT drug in HFpEF with class 2a recommendation. Use them!
🌟Consider screening HFpEF patients for amyloid.
#DAPAHFtrial
English
46 LVAD implants at DHLC this year. Special thanks to our entire team for all their hard work. Looking forward to helping more patients in 2024 with this therapy! Also very thankful to our referring providers for trusting us with their patients .
English
@RyanTedfordMD @Brian_Houston12 @FiedlerAmy @yuzefpolskaya @JasonKatzMD @HajjJennifer @MUSCCardFellows @LizHambrightNP @TheJHLT @MUSC_LVAD Totally agree ! Also we need to move away from “ heart transplant is gold standard “. Third generation VAD is no longer a distant 2nd choice but rather a complimentary to heart transplant
English
One of the most important reads of the year in the AHF world! Let’s stop living in a heartmate 2 world! @Brian_Houston12 @FiedlerAmy @yuzefpolskaya @JasonKatzMD @HajjJennifer @MUSCCardFellows @LizHambrightNP @TheJHLT @MUSC_LVAD
JHLT@TheJHLT
This article proposes questions exploring whether to re-evaluate the processes for LVAD candidacy assessment, transplant vs. LVAD decisions, and management. The ultimate ask, is it time to stop living in a Heartmate II world? @Brian_Houston12 🔗jhltonline.org/article/S1053-…
Houston, TX 🇺🇸 English